QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

DYN

QT85Dyne Therapeutics, Inc.
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
19.80
+0.60+3.13%
OverviewShort InterestFilings
DYNQT85Dyne Therapeutics, Inc.·NASDAQ
OverviewShort InterestFilings
19.80+3.13%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-7.67
Insider Own15.55%
Shs Outstand165.31M
Perf Week10.31%
Market Cap3.17BForward P/E-EPS next Y-2.94Insider Trans-1.71%Shs Float-Perf Month24.37%
Enterprise Value2.44BPEG-EPS next Q-0.74Inst Own-Short Float-Perf Quarter11.24%
Income-452615948.00P/S0.00EPS this Y59.81%Inst Trans-Short Ratio-Perf Half Y1.28%
Sales-P/B3.66EPS next Y4.56%ROA-41.83%Short Interest-Perf YTD1.23%
Book/sh5.23P/C-EPS next 5Y-ROE-58.28%52W High25.00 -20.80%Perf Year82.32%
Cash/sh5.88P/FCF-EPS past 3/5Y-ROIC-45.57%52W Low8.06 145.66%Perf 3Y-
Dividend Est.-EV/EBITDA-5.65Sales past 3/5Y-Gross Margin0.00%Volatility5.23% 4.46%Perf 5Y-
Dividend TTM-EV/Sales0.00EPS Y/Y TTM4.45%Oper. Margin0.00%ATR (14)1.17Perf 10Y-
Dividend Ex-Date-Quick Ratio19.92Sales Y/Y TTM-Profit Margin0.00%RSI (14)60.11Recom2.00
Dividend Gr. 3/5Y-Current Ratio19.92EPS Q/Q30.48%SMA209.21%Beta2.19Target Price35.50
Payout0.00%Debt/Eq0.02Sales Q/Q-SMA508.27%Rel Volume2.69Prev Close19.20
Employees192LT Debt/Eq0.02EarningsJul 27SMA20012.06%Avg Volume1.70MPrice19.80
IPO DateSep 17, 2020Option/ShortYes / YesEPS/Sales Surpr.5.48% -Net Debt/EBITDA1.70Volume4,563,094Change3.13%
Analyst Ratings
DateActionAnalystRatingTarget
May-15-26ReiteratedEvercore ISI$34 → $33
May-13-26ReiteratedBernsteinMarket Perform$23 → $24
Dec-15-25ReiteratedEvercore ISI$38 → $36
Dec-11-25ReiteratedStifel Nicolaus$36 → $39
Dec-10-25UpgradeOppenheimerPerform → Outperform$13 → $40
Dec-09-25ReiteratedTudor Pickering$23
Dec-09-25ReiteratedBernstein$21 → $23
Dec-08-25ReiteratedRobert W. Baird$30
Dec-08-25ReiteratedH.C. Wainwright$46 → $60
Dec-08-25ReiteratedRaymond JamesStrong Buy$35 → $40
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue
1,00800
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A2,93222
Gross Profit-1,924-2-2
Selling, General and Administrative Excl. Other1897062
Research and Development0398281
Other Operating Expense0-2-1
Operating Income-438-468-344
Interest Expense61660
Unusual Expense
———
Non-Operating Income (Expense)235-28-26
Net Income Before Taxes-1,289-446-317
Income Taxes-66000
Consolidated Net Income-1,243-446-317
Net Income From Continuing Operations-1,243-446-317
Net Income-1,243-446-317
EPS (Recurring)-7.67-3.47-3.37
EPS (Basic, Before Extraordinaries)-7.67-3.47-3.37
EPS (Diluted)-7.67-3.47-3.37
EBITDA240-438-315
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio
3.18——
Gross Margin
-190.87——
Operating Margin
-43.45——
Net Margin
-123.31——
Shares Outstanding16212894
Market Capitalization3,2082,504—
Operating Lease Expense
———
Insider Trading Volume
$21.23$19.18$17.13$15.08$13.04● Close Price0.00M9.23M18.46M27.69M36.93MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Cox JohnCEO & PresidentJun 16 '26Sale18.332,68349,179368,151Jun 17 12:00 AM
Friedl-Naderer JohannaChief Commercial OfficerJun 16 '26Sale18.331452,658154,208Jun 17 12:00 AM
Kerr DouglasChief Medical OfficerJun 16 '26Sale18.3388716,259169,155Jun 17 12:00 AM
Posner Brian SDirectorJun 08 '26Buy16.942,00033,88024,500Jun 09 12:00 AM
Posner Brian SDirectorJun 03 '26Buy17.482,50043,70022,500Jun 05 12:00 AM
Posner Brian SDirectorMay 26 '26Buy18.212,00036,42020,000May 28 12:00 AM
Posner Brian SDirectorMay 20 '26Buy17.122,50042,80018,000May 22 12:00 AM
Kerr DouglasChief Medical OfficerMay 13 '26Sale18.361,56428,715170,042May 14 12:00 AM
Friedl-Naderer JohannaChief Commercial OfficerMay 13 '26Sale18.362284,186154,353May 14 12:00 AM
Lucera ErickChief Financial OfficerMay 13 '26Sale18.361,44826,585123,925May 14 12:00 AM
Cox JohnCEO & PresidentMay 13 '26Sale18.363,31160,790370,834May 14 12:00 AM
Rhodes Jason PDirectorMay 06 '26Sale18.1883,2191,512,9227,962May 06 12:00 AM
Rhodes Jason PDirectorMay 05 '26Sale18.0311,600209,1488,390May 06 12:00 AM
Rhodes Jason PDirectorMay 04 '26Sale18.0011,904214,2728,450May 06 12:00 AM
Rhodes Jason PDirectorApr 28 '26Sale18.38227,3374,178,5178,511Apr 30 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR